Earnings
Exelixis Spent $1 Billion On Buybacks In Nine Months, Far More Than Its $640.6 Million Profit
Per-share earnings are climbing as the share count shrinks, while cash fell and a rival cabozantinib product won full FDA approval.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
Per-share earnings are climbing as the share count shrinks, while cash fell and a rival cabozantinib product won full FDA approval.
Earnings
Average premium per policy rose 5.4% in the third quarter, offsetting fewer policies and keeping management fee revenue growing 2.6%.
Deals
The solar company would collect the cash in two installments across 2026 and 2027 from an unnamed corporate buyer.
SEC Filings
Gross margin still slipped to about 49.2% as service sales fell 9%, and the SFE Group deal was funded partly with revolver borrowings.
SEC Filings
The Richmond bank's board raised its common payout by 3 cents and declared a separate preferred dividend, with a yield of about 4.1%.
Earnings
Adjusted operating income was $561 million in the third quarter, while cash flow fell well below a year earlier.
SEC Filings
Longer asset lives cut depreciation by $55.6 million for the nine months, while capital spending fell to $124.0 million.
Earnings
Last year's rate-case true-up flattered the comparison, while the utility's parent presses California for wildfire liability reform by November 15.
SEC Filings
Edison's 10-Q says no wildfire bill passed, and Eaton Fire bellwether trials now run through September 2027.
SEC Filings
Vijayrao, a Meta vice president until August, takes a new board seat and a place on the Compensation Committee.
SEC Filings
The first allocation of the data-center cooling purchase assigns most of the price to goodwill, and a $200 million bonus payout trimmed cash flow growth.
Deals
CEO Mariner Kemper called the California bank purchase a tuck-in, and said UMB would not do a deal that pushes it past $100 billion in assets.